Skip to main content
HR 4619 116th Congress House

Pharmaceutical REPAI Act

Official title: To amend title XVIII of the Social Security Act to require drug manufacturers to pay a Medicare part D rebate for certain drugs if the price of such drugs increases faster than inflation.

Introduced: October 8, 2019 Introduced by: Schakowsky, Janice D. Democratic · Illinois See on congress.gov
Health Business recordsCivil actions and liabilityGovernment information and archivesGovernment trust funds
More subjectsShow fewer subjects
Health care costs and insuranceInflation and pricesMedicarePrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 9, 2019
Referred to the Subcommittee on Health.
Oct 8, 2019
Referred to the Subcommittee on Health.
Oct 8, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 8, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action October 9, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Pharmaceutical Rebates for Excessive Pricing Above Inflation Act or the Pharmaceutical REPAI Act

This bill requires drug manufacturers, subject to civil penalties, to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under the Medicare prescription drug benefit that cost $100 or more and for which the average manufacturer price increases faster than inflation.

 Related & companion bills 1
  • HR 3 Related bill Elijah E. Cummings Lower Drug Costs Now Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4619: Pharmaceutical REPAI Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4619/
MLA
"H.R. 4619: Pharmaceutical REPAI Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4619/.
Bluebook (legal)
H.R. 4619, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4619/.
Markdown link
[H.R. 4619: Pharmaceutical REPAI Act](https://openamerica.io/bill/116-HR-4619/)
Report a problem